openPR Logo
Press release

Cardiac Marker TestingMarket: Global Industry Analysis 2024

05-26-2017 11:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

Cardiac Marker TestingMarket: Global Industry Analysis 2024

Cardiac markers are substances released into the blood when the heart is stressed or damaged. These markers include hormones, enzymes, and proteins. Measuring these biomarkers help to diagnose various heart syndromes such as acute coronary syndrome, cardiac ischemia, and conditions associated with obstructed blood flow to the heart. Generally, multiple cardiac marker tests are done by physicians over several hours to keep track of the blood level rise and to understand the severity of a heart attack.

Get accurate market forecast and analysis on the Cardiac Marker Testing Market. Request a sample to stay abreast on the key trends impacting this market.

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=18671

Geographically, the global cardiac markers testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global cardiac markers testing market due to high incidence of cardiovascular disorders, increasing geriatric population, and growing popularity of point-of-care testing. Asia Pacific is projected to be the fastest growing market during the forecast period, as emerging markets in the region are attracting companies engaged in the development of cardiac biomarkers. Factors such as large population, rising prevalence of CHD, and initiatives taken to spread awareness about cardiac disease diagnosis at an early stage are driving the cardiac markers testing market.

Major players in the global cardiac markers testing market are Siemens Healthineers, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Roche Diagnostics, Abbott Laboratories, LSI Medience Corporation, Randox Laboratories Ltd., Avantra Biosciences, Helomics Corporation, and Enzo Biochem.

Various factors such as increasing funds by various organizations to stimulate research & clinical trials in biomarker testing and rising geriatric population are driving the cardiac markers testing market. However, problems regarding reimbursement and regulatory system, and sample collection and storage are restraining the cardiac markers testing market. Determining cardiac marker levels in the laboratory takes substantial time. Hence, cardiac markers are not useful in diagnosing a myocardial infarction in the acute phase. This in turn restrains the cardiac markers testing market.

Browse Global Strategic Business Report: http://www.transparencymarketresearch.com/cardiac-marker-testing-market.html

In terms of product type, the global cardiac markers testing market has been segmented into creatine kinase (CK), lactate dehydrogenase, AST, troponin, myoglobin, C-reactive proteins, natriuretic peptides, and others. The creatine kinase segment is sub-segmented into M & B subunits: CK-MM, CK-MB, and CK-BB. The troponin cardiac biomarkers segment held the largest share of the global cardiac markers testing market in 2015 and is anticipated to dominate the market during the forecast period. This is attributed to its efficiency and accuracy in test results to diagnose cardiovascular disorders. Based on application, the global cardiac markers market is divided into markers utilized for myocardial infarction, acute coronary syndrome (ACS), cardiac heart failure, and others. ACS is estimated to be the fasting growing segment driven by increasing prevalence of the disorder. Myocardial infarction is projected to be the second fastest growing segment, attributed to increasing rate of sedentary lifestyle among individuals, alcohol consumption, smoking, and unhealthy food habits, leading to obesity. In terms of end-user, the global cardiac markers testing market has been segmented into point-of-care testing and laboratory testing. The laboratory testing segment held the largest share of the global cardiac markers testing market in 2015, while the point-of-care testing segment is anticipated to gain comparatively larger market share during the forecast period. This is attributed to easy-to-use kits, availability of the technique in ambulances in some countries in Europe, and affordability for patients as the point-of-care diagnostic tool reduces expenditure on hospitals, thereby increasing the adoption rate of new diagnostic tools.

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cardiac Marker TestingMarket: Global Industry Analysis 2024 here

News-ID: 553692 • Views: 555

More Releases from Transparency Market Research

Dielectric Gases Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Dielectric Gases Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Dielectric Gases market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Dielectric Gases market over the
Oxalic Acid Market Size will Observe Lucrative Surge by the End 2027
Overview TMR’s report on the Oxalic Acid Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Oxalic Acid market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Oxalic Acid market over the
Long Fiber Thermoplastics Market Shares, Strategies and Opportunities 2027
Overview TMR’s report on the Long Fiber Thermoplastics Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the Long Fiber Thermoplastics market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the Long Fiber Thermoplastics
High Performance Foaming Agents Market Size will Observe Lucrative Surge by the …
Overview TMR’s report on the High Performance Foaming Agents Market is an all-important tool for market stakeholders in their pursuit to discover avenues for innovation, and further undertake strategic planning for the launch of products and services. Our research report on the High Performance Foaming Agents market serves as a valuable guide for market stakeholders. The report deep dives into demand drivers, challenges, and opportunities that are likely to influence the High

All 5 Releases


More Releases for Cardiac

Global Cardiac Monitoring & Cardiac Rhythm Management Market Insights, Forecast
Cardiac monitoring (CM) devices help in continuous examination of a patient’s cardiac activity. Cardiac rhythm management (CRM) devices maintain normal cardiac rhythm in patients suffering from rate and rhythm disorders of the heart. These devices play a crucial role in the treatment of serious cardiac disorders, including heart failure, atrial fibrillation, atrial flutter, indications of recent heart attack, coronary ischemia, lack of oxygen supply to cardiac muscles, effects of drugs,
Ambulatory Cardiac Monitoring Devices
Ambulatory Cardiac Monitoring Devices Market by Product (Ambulatory Rhythm Monitor, Ambulatory ECG Monitor, Ambulatory Cardiac Event Monitor, Implantable Loop Recorder, Ambulatory real-time Cardiac Monitors, Cardiac Output Monitors); by End-User (Hospitals, Ambulatory Care Centers); by Region (U.S., Rest of North America, France, UK, Germany, Spain, Italy, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, GCC Countries, Southern Africa, Rest of MEA, Brazil, Rest of Latin America) –
Cardiac Monitoring & Cardiac Rhythm Management Devices Market Stupendous Growth …
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are
Mexico Cardiac Assist Devices
Mexico Cardiac Assist Devices Overview "Mexico Cardiac Assist Devices Market Outlook to 2025", provides key market data on the Mexico Cardiac Assist Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Intra-Aortic Balloon Pumps, Total Artificial Heart and Ventricular Assist Devices. Click here for sample report @ https://www.wiseguyreports.com/sample-request/3107735-mexico-cardiac-assist-devices-market-outlook-to-2025   Major Key Players: Abbott Laboratories Medtronic plc Getinge AB. Major Highlight of the report: The report also provides
Cardiac Monitoring & Cardiac Rhythm Management Market Review and Forecast 2025
Crystalmarketresearch.com published “Cardiac Monitoring & Cardiac Rhythm Management Market By Component, Technology, Application, And End User - Global Industry Analysis And Forecast To 2025” from its database. The report reviews top companies involved and enlists all trials pertaining to the company. The cardiac monitoring & cardiac rhythm management market is expected to be worth $XX billion by 2025. The market is largely driven by factors such as rising incidence of cardiovascular
Cardiac Monitoring & Cardiac Rhythm Management Devices Market
Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Snapshot The global cardiac monitoring and cardiac rhythm management devices market is driven by growing incidences of cardiovascular diseases and growing private institutional home care and nursing. The technological advancements in the medical sector have helped develop innovative products and this is furthering the growth of the cardiac monitoring and cardiac rhythm management devices market. The rising treatment costs of cardiac diseases are